The Janssen PhD Scholarship Program for AI in Medicine is empowering two students in the inaugural cohort of our AIM PhD track. Lucía Morris and Romain Hardy will have two years of attendance as well as associated research and educational activities supported by a contribution of $500,000 from Janssen. 

Prior to entering the program, Lucía received both a BS and MS in Computer Science from Stanford University in the Biocomputation Track. Her research interests include developing distributed machine learning systems that use electronic health record (EHR) data to improve patient diagnosis and treatment

Romain attended University of California, Berkeley, and received a BA in Mathematics and Astrophysics and MS in Information and Data Science. He is interested in biomedical applications of generative AI, such as clinical report generation and de novo protein design.

"It is with great pleasure that I write to memorialize Janssen’s support of the Harvard Medical School PhD Program in AI in Medicine. Our company is honored...to support the costs of attendance as well as associated research and educational activities for graduate students in the program," said Najat Khan, former Chief Data Sciences Officer and Global Head of Strategy and Operations at Janssen. 

Janssen scientists Ali Samadani and Jocelyn Wang, shown above, recently attended DBMI's annual Science Day retreat. Each year at Science Day, faculty and their lab members present an overview of their work so that new students may begin to seek out mentors and collaborators for their time at DBMI.

The PhD track is co-directed by Zak Kohane, chair of DBMI, and Sebastian Schneeweiss, who is Chief of the Division of Pharmacoepidemiology and Pharmacoeconomics at Brigham and Women's Hospital, Professor of Medicine at Harvard Medical School and Professor in Epidemiology at the Harvard T.H. Chan School of Public Health.